Pharmacogenomic and drug interaction risk associations with hospital length of stay among Medicare Advantage members with COVID-19
Kristine Ashcraft, Chad Moretz, Chantelle Schenning, View ORCID ProfileSusan Rojahn, Kae Vines Tanudtanud, Gwyn Omar Magoncia, Justine Reyes, Bernardo Marquez, Yinglong Guo, Elif Tokar Erdemir, Taryn O. Hall
doi: https://doi.org/10.1101/2021.05.06.21256769
Kristine Ashcraft
1Invitae Corporation, 1400 16th St, San Francisco, CA 94103
MBAChad Moretz
1Invitae Corporation, 1400 16th St, San Francisco, CA 94103
ScDChantelle Schenning
1Invitae Corporation, 1400 16th St, San Francisco, CA 94103
PhDSusan Rojahn
1Invitae Corporation, 1400 16th St, San Francisco, CA 94103
PhDKae Vines Tanudtanud
2OptumLabs at UnitedHealth Group, 5995 Opus Parkway, Minnetonka, MN 55343
MSGwyn Omar Magoncia
2OptumLabs at UnitedHealth Group, 5995 Opus Parkway, Minnetonka, MN 55343
BSJustine Reyes
2OptumLabs at UnitedHealth Group, 5995 Opus Parkway, Minnetonka, MN 55343
BSBernardo Marquez
2OptumLabs at UnitedHealth Group, 5995 Opus Parkway, Minnetonka, MN 55343
PhDYinglong Guo
2OptumLabs at UnitedHealth Group, 5995 Opus Parkway, Minnetonka, MN 55343
MSElif Tokar Erdemir
2OptumLabs at UnitedHealth Group, 5995 Opus Parkway, Minnetonka, MN 55343
PhDTaryn O. Hall
2OptumLabs at UnitedHealth Group, 5995 Opus Parkway, Minnetonka, MN 55343
MPH, PhDData Availability
The data analyzed in this study was obtained from UnitedHealth Group Clinical Discovery Portal. The data are proprietary and are not available for public use but, under certain conditions, may be made available to editors and their approved auditors under a data-use agreement to confirm the findings of the current study. Further inquiries can be directed to Lauren Mihajlov.
Posted May 13, 2021.
Pharmacogenomic and drug interaction risk associations with hospital length of stay among Medicare Advantage members with COVID-19
Kristine Ashcraft, Chad Moretz, Chantelle Schenning, Susan Rojahn, Kae Vines Tanudtanud, Gwyn Omar Magoncia, Justine Reyes, Bernardo Marquez, Yinglong Guo, Elif Tokar Erdemir, Taryn O. Hall
medRxiv 2021.05.06.21256769; doi: https://doi.org/10.1101/2021.05.06.21256769
Pharmacogenomic and drug interaction risk associations with hospital length of stay among Medicare Advantage members with COVID-19
Kristine Ashcraft, Chad Moretz, Chantelle Schenning, Susan Rojahn, Kae Vines Tanudtanud, Gwyn Omar Magoncia, Justine Reyes, Bernardo Marquez, Yinglong Guo, Elif Tokar Erdemir, Taryn O. Hall
medRxiv 2021.05.06.21256769; doi: https://doi.org/10.1101/2021.05.06.21256769
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (679)
- Anesthesia (182)
- Cardiovascular Medicine (2685)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12318)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4161)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2699)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3935)
- Nursing (213)
- Nutrition (586)
- Oncology (2073)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (462)
- Public and Global Health (6583)
- Radiology and Imaging (1424)
- Respiratory Medicine (877)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)